SlideShare a Scribd company logo
1 of 1
Download to read offline
info@SmartMedicalConsulting.com
TOXICOLOGY
PHARMACOGENOMICS
888.401.9997 www.SmartMedicalConsulting.com
“Prescribe with
Confidence”
OUR COMMITMENT
HPLC-Tandem mass spectrometry
testing
Highly trained scientists
Clinical Consultations
Customizable testing with over 70
individual analytes
Rapid 48-72 hour turnaround time
Industry leading report format in both
expanded & condensed versions.
Pharmacogenomics is the relationship
between a patients unique genetic
makeup & their response to certain
medications.
This is very important testing to assist
clinicians’ medication selections as
well as dosages, leading to targeted
& personalized therapy.
This is a one-time oral DNA test to
analyze patient samples in a rapid &
accurate fashion by our team of
highly trained scientists.
Toxicology testing provides important
information about the medication
and other substances in the patient’s
system from either urine or oral fluid
samples. This information helps guide
a clinician’s treatment of a patient. In
addition, this testing ensures the safe
use of prescriptions and is designed
to help doctors provide the highest
level of care.
Aeon offers the most accurate and
rapid quantitative testing for urine
and oral fluid drug and metabolite
levels.
Smart Medical Consulting
TOXICOLOGY
&Pharmacogenomics

More Related Content

What's hot

Quality assurance scheme for basic composite medical laboratories
Quality assurance scheme for basic composite medical laboratoriesQuality assurance scheme for basic composite medical laboratories
Quality assurance scheme for basic composite medical laboratoriesjdyjdo
 
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...Innovation Agency
 
Poct diabetes mellitus
Poct diabetes mellitusPoct diabetes mellitus
Poct diabetes mellitusjdyjdo
 
Applying Technology to Anticoagulation
 Applying Technology to Anticoagulation Applying Technology to Anticoagulation
Applying Technology to AnticoagulationHIMSS UK
 
Java Clinical Research at the Research and Innovation Conference
Java Clinical Research at the Research and Innovation ConferenceJava Clinical Research at the Research and Innovation Conference
Java Clinical Research at the Research and Innovation ConferenceRuth Nallen
 
Point of care testing
Point of care testingPoint of care testing
Point of care testingkamalmodi481
 
Drug Discovery - What Happens after FDA Approval?
Drug Discovery - What Happens after FDA Approval?Drug Discovery - What Happens after FDA Approval?
Drug Discovery - What Happens after FDA Approval?Lindsay Rosenwald
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperRandox
 
Pharmacy Driven Chemotherapy and Monoclonal Antibody Dose-Rounding: A Cost-Sa...
Pharmacy Driven Chemotherapy and Monoclonal Antibody Dose-Rounding: A Cost-Sa...Pharmacy Driven Chemotherapy and Monoclonal Antibody Dose-Rounding: A Cost-Sa...
Pharmacy Driven Chemotherapy and Monoclonal Antibody Dose-Rounding: A Cost-Sa...ErisTollkuciPharmDBC
 
Analytical and post analytical errors in laboratory
Analytical and post analytical errors in laboratoryAnalytical and post analytical errors in laboratory
Analytical and post analytical errors in laboratoryHanisha Erica Villaester
 
Optimizing Protocol Design and Enhancing Patient Enrollment Case Study
Optimizing Protocol Design and Enhancing Patient Enrollment Case Study Optimizing Protocol Design and Enhancing Patient Enrollment Case Study
Optimizing Protocol Design and Enhancing Patient Enrollment Case Study Covance
 
Discount discount.....research aarkstore enterprise companion diagnostics in ...
Discount discount.....research aarkstore enterprise companion diagnostics in ...Discount discount.....research aarkstore enterprise companion diagnostics in ...
Discount discount.....research aarkstore enterprise companion diagnostics in ...Neel Terde
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacyPrajith V
 

What's hot (19)

Quality assurance scheme for basic composite medical laboratories
Quality assurance scheme for basic composite medical laboratoriesQuality assurance scheme for basic composite medical laboratories
Quality assurance scheme for basic composite medical laboratories
 
CPOE
CPOECPOE
CPOE
 
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
 
Poct diabetes mellitus
Poct diabetes mellitusPoct diabetes mellitus
Poct diabetes mellitus
 
Applying Technology to Anticoagulation
 Applying Technology to Anticoagulation Applying Technology to Anticoagulation
Applying Technology to Anticoagulation
 
Java Clinical Research at the Research and Innovation Conference
Java Clinical Research at the Research and Innovation ConferenceJava Clinical Research at the Research and Innovation Conference
Java Clinical Research at the Research and Innovation Conference
 
Point of care testing
Point of care testingPoint of care testing
Point of care testing
 
Drug Discovery - What Happens after FDA Approval?
Drug Discovery - What Happens after FDA Approval?Drug Discovery - What Happens after FDA Approval?
Drug Discovery - What Happens after FDA Approval?
 
Drug Test Cheaters
Drug Test CheatersDrug Test Cheaters
Drug Test Cheaters
 
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White PaperQuality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White Paper
 
Phase 0 clinical trial
Phase 0 clinical trialPhase 0 clinical trial
Phase 0 clinical trial
 
Pharmacy Driven Chemotherapy and Monoclonal Antibody Dose-Rounding: A Cost-Sa...
Pharmacy Driven Chemotherapy and Monoclonal Antibody Dose-Rounding: A Cost-Sa...Pharmacy Driven Chemotherapy and Monoclonal Antibody Dose-Rounding: A Cost-Sa...
Pharmacy Driven Chemotherapy and Monoclonal Antibody Dose-Rounding: A Cost-Sa...
 
Analytical and post analytical errors in laboratory
Analytical and post analytical errors in laboratoryAnalytical and post analytical errors in laboratory
Analytical and post analytical errors in laboratory
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokinetics
 
Optimizing Protocol Design and Enhancing Patient Enrollment Case Study
Optimizing Protocol Design and Enhancing Patient Enrollment Case Study Optimizing Protocol Design and Enhancing Patient Enrollment Case Study
Optimizing Protocol Design and Enhancing Patient Enrollment Case Study
 
Discount discount.....research aarkstore enterprise companion diagnostics in ...
Discount discount.....research aarkstore enterprise companion diagnostics in ...Discount discount.....research aarkstore enterprise companion diagnostics in ...
Discount discount.....research aarkstore enterprise companion diagnostics in ...
 
Medication error
Medication errorMedication error
Medication error
 
Oncoustics
OncousticsOncoustics
Oncoustics
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
 

Viewers also liked

“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”Fred Jorgensen
 
Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Elsa von Licy
 
Metabolism of drugs to toxic products
Metabolism of drugs to toxic productsMetabolism of drugs to toxic products
Metabolism of drugs to toxic productsDr Aakifa Javed
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolismRIPS-14
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolismraj kumar
 
Urine Toxicology Testing
Urine Toxicology TestingUrine Toxicology Testing
Urine Toxicology Testingyury
 
Lecture 10
Lecture 10Lecture 10
Lecture 10ammar905
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolismsuniu
 

Viewers also liked (10)

Chain of custody
Chain of custodyChain of custody
Chain of custody
 
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
“The Value of Drug Monitoring in Chronic Opioid Therapy Patients”
 
Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013
 
Metabolism of drugs to toxic products
Metabolism of drugs to toxic productsMetabolism of drugs to toxic products
Metabolism of drugs to toxic products
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 
Urine Toxicology Testing
Urine Toxicology TestingUrine Toxicology Testing
Urine Toxicology Testing
 
Metabolism of drug
Metabolism of drugMetabolism of drug
Metabolism of drug
 
Lecture 10
Lecture 10Lecture 10
Lecture 10
 
Drug metabolism
Drug metabolismDrug metabolism
Drug metabolism
 

Similar to SMART Tox Flyer copy

Solaris bio cellular analysis
Solaris bio cellular analysisSolaris bio cellular analysis
Solaris bio cellular analysiszmusial
 
Back Rapid lead compounds discovery through high-throughput screening
 Back Rapid lead compounds discovery through high-throughput screening Back Rapid lead compounds discovery through high-throughput screening
Back Rapid lead compounds discovery through high-throughput screeningrita martin
 
HIGH THROUGHPUT SCREENING Technology
HIGH THROUGHPUT SCREENING  TechnologyHIGH THROUGHPUT SCREENING  Technology
HIGH THROUGHPUT SCREENING TechnologyUniversity Of Swabi
 
General Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringGeneral Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringDr. Ramesh Bhandari
 
Toxicology screening and therapeutic drug monitoring (an introduction)
 Toxicology screening and therapeutic drug monitoring (an introduction)  Toxicology screening and therapeutic drug monitoring (an introduction)
Toxicology screening and therapeutic drug monitoring (an introduction) Hossamaldin Alzawawi
 
THERAPEUTIC DRUG MONITORING S KOSEY
THERAPEUTIC DRUG MONITORING S KOSEYTHERAPEUTIC DRUG MONITORING S KOSEY
THERAPEUTIC DRUG MONITORING S KOSEYsopi_1234
 
High Throughput Screening Technology
High Throughput Screening TechnologyHigh Throughput Screening Technology
High Throughput Screening TechnologyUniversity Of Swabi
 
Drug Development Process
Drug Development ProcessDrug Development Process
Drug Development ProcessTusharJ7
 
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCSBIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCSChinmayaSahoo28
 
PreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfPreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfsayedjannatfatema72
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kineticspharmacistnitish
 
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdfPathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdfPriyankapandey782070
 
Introduction to the drug discovery process
Introduction to the drug discovery processIntroduction to the drug discovery process
Introduction to the drug discovery processThanh Truong
 
Unit 5: Clinical trials & Regulatory guidelines
Unit 5: Clinical trials & Regulatory guidelinesUnit 5: Clinical trials & Regulatory guidelines
Unit 5: Clinical trials & Regulatory guidelinesAshok Kumar
 
Bioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.pptBioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.pptDr. Manoj Kumbhare
 
Special concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalenceSpecial concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalencePradnya Shirude
 

Similar to SMART Tox Flyer copy (20)

Solaris bio cellular analysis
Solaris bio cellular analysisSolaris bio cellular analysis
Solaris bio cellular analysis
 
Back Rapid lead compounds discovery through high-throughput screening
 Back Rapid lead compounds discovery through high-throughput screening Back Rapid lead compounds discovery through high-throughput screening
Back Rapid lead compounds discovery through high-throughput screening
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
presentation.pptx
presentation.pptxpresentation.pptx
presentation.pptx
 
HIGH THROUGHPUT SCREENING Technology
HIGH THROUGHPUT SCREENING  TechnologyHIGH THROUGHPUT SCREENING  Technology
HIGH THROUGHPUT SCREENING Technology
 
General Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringGeneral Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoring
 
Toxicology screening and therapeutic drug monitoring (an introduction)
 Toxicology screening and therapeutic drug monitoring (an introduction)  Toxicology screening and therapeutic drug monitoring (an introduction)
Toxicology screening and therapeutic drug monitoring (an introduction)
 
Rm genetics
Rm geneticsRm genetics
Rm genetics
 
THERAPEUTIC DRUG MONITORING S KOSEY
THERAPEUTIC DRUG MONITORING S KOSEYTHERAPEUTIC DRUG MONITORING S KOSEY
THERAPEUTIC DRUG MONITORING S KOSEY
 
CLINICAL TRIALS.pptx
CLINICAL TRIALS.pptxCLINICAL TRIALS.pptx
CLINICAL TRIALS.pptx
 
High Throughput Screening Technology
High Throughput Screening TechnologyHigh Throughput Screening Technology
High Throughput Screening Technology
 
Drug Development Process
Drug Development ProcessDrug Development Process
Drug Development Process
 
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCSBIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
BIOEQUIVALENCE,BIOSIMILARDRUGPRODUCTS,ANDBCS
 
PreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdfPreClinical Development_Final_clinical.pdf
PreClinical Development_Final_clinical.pdf
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
 
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdfPathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
Pathology Labs Advancing Diagnostics and Healthcare Outcomes - Presentation.pdf
 
Introduction to the drug discovery process
Introduction to the drug discovery processIntroduction to the drug discovery process
Introduction to the drug discovery process
 
Unit 5: Clinical trials & Regulatory guidelines
Unit 5: Clinical trials & Regulatory guidelinesUnit 5: Clinical trials & Regulatory guidelines
Unit 5: Clinical trials & Regulatory guidelines
 
Bioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.pptBioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.ppt
 
Special concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalenceSpecial concerns in bioavaliblity and bioeqvivalence
Special concerns in bioavaliblity and bioeqvivalence
 

SMART Tox Flyer copy

  • 1. info@SmartMedicalConsulting.com TOXICOLOGY PHARMACOGENOMICS 888.401.9997 www.SmartMedicalConsulting.com “Prescribe with Confidence” OUR COMMITMENT HPLC-Tandem mass spectrometry testing Highly trained scientists Clinical Consultations Customizable testing with over 70 individual analytes Rapid 48-72 hour turnaround time Industry leading report format in both expanded & condensed versions. Pharmacogenomics is the relationship between a patients unique genetic makeup & their response to certain medications. This is very important testing to assist clinicians’ medication selections as well as dosages, leading to targeted & personalized therapy. This is a one-time oral DNA test to analyze patient samples in a rapid & accurate fashion by our team of highly trained scientists. Toxicology testing provides important information about the medication and other substances in the patient’s system from either urine or oral fluid samples. This information helps guide a clinician’s treatment of a patient. In addition, this testing ensures the safe use of prescriptions and is designed to help doctors provide the highest level of care. Aeon offers the most accurate and rapid quantitative testing for urine and oral fluid drug and metabolite levels. Smart Medical Consulting TOXICOLOGY &Pharmacogenomics